HEALTHeUNIVERSE, Inc. (OTCPK: HLUN)
Health Care · Biotechnology · US
$—
— today · — 1Y
HEALTHeUNIVERSE, Inc. (OTCPK: HLUN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $118.00 and employs 0 people.
trading between 0.00 and 0.00.
Tweenvest scores HEALTHeUNIVERSE, Inc. across four factors: value 50/100. Its strongest factor is value.
HLUN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $118.00
- Revenue (TTM)
- $481.79K
- P/E
- 0.00
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- 147.78
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 117.78M
- Employees
- 0
- Next earnings
- —
About HEALTHeUNIVERSE, Inc.
Healtheuniverse, Inc. operates as a biotechnology firm dedicated to exploring, creating, and bringing to market a diverse range of biopharmaceutical, biomedical, nutraceutical, and cosmeceutical products. A key focus involves advancing regenerative medicine and stem cell treatments, specifically employing non-embryonic adult stem cells. These therapies are designed for applications across multiple medical specialties, such as reconstructive and plastic surgery, orthopedics, vascular procedures, heart surgery, and wound management. Additionally, the company extends its expertise through consulting services, assisting various enterprises with strategic marketing, organizational structuring, and securing funding for their initiatives. Established in 2001, its primary operational base is located in Covina, California.
- ISIN
- US42224J1007
- Founded
- 2001
- Listed since
- Feb 20, 2013
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.